Customized Care Plans : Treatment is individualized, factoring in each patients medical history, goals, and progress
obesity + T2D, highest dose: Retatrutide: 28.3% 20.8% Semaglutide 7.2 mg: 20.7% 14.1% Orforglipron: 12.4% 10.5% Placebo-adjusted, retatrutide 12 mg delivered about two-thirds of the effect in type 2 diabetes that it delivered in the non-diabetic TRIUMPH-1 cohort 16.8 points versus 26.1 points
Additionally, 37% of Wegovy users saw improvements in fibrosis (scarring)
Addressing hormonal imbalances alongside semaglutide often reignites stalled progress
These programs provide ongoing encouragement and accountability, helping patients stay on track with their weight loss goals
When you do need more electrolytes, weve got you covered